Sort
3,198 grants matching “mrna vaccine”
Collaborative Research: Development of an exosome based lipoproteoplex (E-LPP) for siRNA delivery
$249,999Piul S Rabbani · New York University Medical Center · · FY2022 · MPS
Manipulating nucleic acids: applications in RNA biosensing, single-molecule analysis, and DNA nanotechnology
$249,950Ken A Halvorsen · State University Of New York At Albany · R35 · FY2023 · GM
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
$249,863Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2023 · AI
Gene Expression Profiling of Normal Tissues
$249,710Javed Khan · Basic Sciences · Z01 · FY2007 · CA
LANGERHANS CELL TARGETED GENETIC VACCINE AGAINST HIV1
$249,360University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · AI
Transcriptome profiling of Trypanosoma cruzi and its host cell
$249,298Barbara A Burleigh · Harvard School Of Public Health · R21 · FY2011 · AI
Targeting Cancer at the Protein-Membrane Interface
$249,000Johannes Morstein · California Institute Of Technology · R00 · FY2025 · CA
Engineering viral nanoparticles for TLR agonist-based multi-functional cancer immunotherapies
$249,000Zhongchao Zhao · University Of California At Davis · R00 · FY2025 · CA
Assessment of Clinical Grade Near-Native Cleavage-Independent Trimer Protein Compared to Membrane-Bound mRNA Expression Coupled with Glycan Deletion, Restoration and Heterologous Boosting
$248,861Pyone Aye · Tulane University Of Louisiana · N01 · FY2025 · AI
Translational Control in Plasmodium Sexual Development
$248,612Pennsylvania State University-Univ Park · R01 · FY2003 · AI
EHRLICHIACIDAL MECHANISM BY LEUKOCYTES
$247,928Ohio State University · R01 · FY2002 · AI
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
$247,824Michael N Starnbach · Harvard Medical School · R21 · FY2023 · AI
Novel antiviral targets in Ebola and Marburg virus polymerases
$247,710Sean P. J. Whelan · Harvard Medical School · U54 · FY2012 · AI
Identifying target antigens for Cryptosporidium vaccine
$247,500Saul R Tzipori · Tufts University Boston · R21 · FY2020 · AI
Identification of protective innate immune memory responses against HIV acquisition in the human female genital tract
$247,500Marta Rodriguez Garcia · Tufts University Boston · R21 · FY2022 · AI
Activation of STING-mediated pathway(s) in T cells
$247,500Alexander Poltorak · Tufts University Boston · R21 · FY2017 · AI
Determining the impact of respiratory syncytial virus M2-1 protein on post-transcriptional regulation of cellular and viral mRNAs
$247,500Rachel Fearns · Boston University Medical Campus · R21 · FY2023 · AI
RNA encoded nanobody-based immunotherapeutics targeting essential, host-interactive schistosome ectoenzymes
$247,500Patrick J Skelly · Tufts University Boston · R21 · FY2023 · AI
Gonococcal In-vivo Expressed Factors (IVEFs) as novel vaccine antigens against N. gonorrhoeae infection
$247,500Paola Massari · Tufts University Boston · R21 · FY2019 · AI
Emerging infections: surveillance, epidemiology and pathogenesis
$247,061David Wang · Washington University · U01 · FY2022 · AI
Defining the Protective vs. Susceptible Immune Proteome of S. aureus Osteomyelitis
$246,856Edward M Schwarz · University Of Rochester · P50 · FY2025 · AR
Immunologic Studies Associated with COVID-19
$246,576Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Polyadenylation Factors in B-Cells, Lymphoma & Myeloma
$246,408Christine A. Milcarek · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
A Non-Viral Genetic Vaccine for Prevention and Treatment of Multiple Sclerosis
$245,625Jordan Green · Johns Hopkins University · R21 · FY2022 · AI
Ribosome profiling of Trypanosoma brucei
$245,625Peter John Myler · Seattle Biomedical Research Institute · R21 · FY2012 · AI